Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
PASG
#4481
Passage Bio, Inc. Common Stock
10.860
0
USD
+0.46%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+0.46%
Changement Mensuel
+44.03%
Evolution sur 6 mois
+22.85%
Changement Annuel
+22.85%
Clôture Précédente
10.810
0
Open
10.860
0
Bid
Ask
Low
10.860
0
High
10.860
0
Volume
4
Marchés
Actions des Marchés US
Soins de Santé
PASG
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
2.69 M
2.71 M
2.73 M
2.78 M
3.11 M
3.21 M
—
Valuation ratios
Enterprise value
1.24 B
215.79 M
53.88 M
28.39 M
-2.33 M
-8.45 M
-109.29 M
Price to earnings ratio
—
-1.82
-0.65
-0.48
-0.53
-0.82
-2.15
Price to sales ratio
—
—
—
-106.54
34.71
25.52
76.94
Price to cash flow ratio
—
-2.67
-0.75
-0.63
-0.71
-1.19
-3.13
Price to book ratio
—
1.06
0.44
0.44
0.56
2
2.33
Enterprise value to EBITDA ratio
—
—
—
-0.64
0.09
0.35
4.4
Profitability ratios
Return on assets %
-0.34
-0.52
-0.56
-0.68
-0.63
-0.73
-0.61
Return on equity %
-0.37
-0.58
-0.68
-0.92
-1.06
-2.43
-1.52
Return on invested capital %
-1 311.26
-1 527.49
-819.29
-737.43
-492.97
—
—
Gross margin %
—
—
—
100
100
100
400
Operating margin %
—
—
—
23.41 K
-7 132.73
-3 360.33
-13.45 K
EBITDA margin %
—
—
—
9 541.04
-2 649.75
-1 624.06
-6 498.52
Net margin %
—
—
—
22.04 K
-6 562.01
-3 103.07
-12.42 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
14.98
11.02
10.74
7.22
4.07
2.07
11.36
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
-0
0.01
0.02
0.02
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-47.57
-43.44
-28.59
-15.88
-9.93
-10.03
EBIT per share
—
—
—
-17.5
-9.68
-7.74
-7.79
EBITDA per share
—
—
—
-16.14
-8.66
-7.51
-7.56
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
118.39
69.67
41.76
25.41
14.59
69.78
Net current asset value per share
—
121.88
72.4
43.1
26.1
15.05
73.09
Tangible book value per share
—
119.47
73.99
40.66
20.28
5.91
42.81
Working capital per share
—
110.82
65.66
37.13
19.68
7.78
46.83
Book value per share
—
119.47
73.99
40.66
20.28
5.91
42.81
Nouvelles
Baird initie la couverture de Passage Bio avec une recommandation surperformance
Oppenheimer initie la couverture de Passage Bio avec une recommandation surperformance
Lucid Capital Markets initie la couverture de Passage Bio avec une recommandation d’achat
Lucid Capital Markets initiates Passage Bio stock with Buy rating
Monday’s Insider Moves: Key Buys and Sells in US Stocks Revealed
Lynx1 Capital achète des actions de Passage Bio (PASG) pour 223.734$
Lynx1 Capital buys Passage Bio (PASG) shares worth $223,734
Wall Street Analysts Think Passage Bio (PASG) Could Surge 731%: Read This Before Placing a Bet
Wall Street Analysts Believe Passage Bio (PASG) Could Rally 1415.15%: Here's is How to Trade
Guggenheim lowers Passage Bio stock price target to $10 from $40
Canaccord Genuity lowers Passage Bio stock price target to $67 from $260
Lynx1 capital buys Passage Bio (PASG) shares worth $733,825